ReCor Medical
Nabil Lahdou is an accomplished finance professional with extensive experience in accounting and regulatory reporting across various companies in the EMEA region. Currently serving as the Accounting Director for ReCor Medical since June 2023, Nabil's previous roles include Head of Accounting/Tax/Regulatory Reporting and Senior Manager of Accounting & Tax at Hyundai Capital Bank Europe GmbH from November 2016 to June 2023. Prior to that, Nabil held the position of Senior Manager of Accounting & Tax at Hyundai Capital Europe GmbH and Finance Manager for Germany at Fortress Investment Group. Early career experience includes serving as a Tax Assistant for EMEA at Henry Schein from April 2010 to December 2012.
This person is not in any offices
ReCor Medical
ReCor Medical has developed a unique therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The PARADISE® technology (Percutaneous Renal Denervation System) includes a 6 French catheter with a cylindrical transducer that emits ultrasound energy circumferentially, allowing for a moreefficient renal denervation procedure.